Our Opinion: Most Hair Loss Products Are a Waste of Money

The hair loss industry generates $4.5 billion annually. The majority of that revenue comes from products with no meaningful clinical evidence — shampoos that promise regrowth, vitamins marketed as follicle miracles, and laser devices with weak data and big price tags.

This site exists to give you a straight opinion on what works, backed by the evidence that supports it. We're not neutral on every product — we have a point of view, and we'll tell you what it is and why. When something works, we'll say so. When it doesn't, we'll say that too.

Key Terms Defined

Androgenetic Alopecia

Androgenetic alopecia, commonly referred to as male pattern baldness, is defined as a progressive thinning of scalp hair caused by a genetic sensitivity to dihydrotestosterone (DHT). It is the most common form of hair loss in men, accounting for roughly 95% of cases. What is androgenetic alopecia in practical terms? It is the gradual miniaturization of hair follicles — primarily at the temples and crown — driven by the hormone DHT binding to androgen receptors in genetically predisposed follicles.

DHT (Dihydrotestosterone)

DHT refers to a potent androgen hormone that your body produces from testosterone via the enzyme 5-alpha-reductase. What is DHT's role in hair loss? It binds to receptors in susceptible scalp follicles, triggering each successive growth cycle to produce thinner, shorter hair until the follicle eventually goes dormant. Blocking DHT production or receptor binding is the mechanism behind every clinically validated hair loss treatment.

Follicle Miniaturization

Follicle miniaturization is defined as the progressive shrinking of hair follicles over successive growth cycles, caused by chronic DHT exposure. Each cycle produces a finer, shorter strand until only vellus (peach-fuzz) hair remains. Once a follicle reaches full dormancy, no current treatment — pharmaceutical or natural — can reactivate it, which is why early intervention is critical.